CONFERENCE PROCEEDING
Determining the feasibility of a pharmacistdelivered smoking cessation intervention for rural smokers in partnership with independent community pharmacies
 
More details
Hide details
1
Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, United States
 
 
Publication date: 2022-07-05
 
 
Tob. Prev. Cessation 2022;8(Supplement):A31
 
ABSTRACT
Background:
Tobacco use disparities exist despite the widespread dissemination of evidence-based tobacco cessation interventions. Pharmacists are under-utilized community resources to address tobacco control, given their centralized placement in the community, clinical expertise and frequent patient interactions; however, pharmacists rarely provide tobacco cessation services to their customers due to a lack of standardized, reimbursable programs.

Objective:
The goal of this study was to determine the feasibility of delivering a smoking cessation intervention through independent pharmacies in rural communities that uses a standard documentation and billing system for pharmacy reimbursement of services.

Methods:
Twenty-four rural smokers were randomized in a fully crossed factorial design to: 1) QuitAid, a pharmacist delivered novel 5 session intervention (Yes vs No); 2) Combination nicotine replacement therapy (NRT) Gum + NRT Patch (vs NRT patch alone); and/or 3) 8 weeks of NRT (vs standard 4 weeks). The primary outcomes were the feasibility of the approach, as measured by feasibility of recruitment, randomization, and retention.

Results:
Participants were recruited within 7 weeks using an ask-adviseconnect method (66%) at a local independent pharmacy, while the rest were self-referred from store signage (16%), prescription bag advertisements (4%) and word of mouth (16%). Over 82% of the QuitAid sessions were completed, and 83% of participants were retained at the follow-up at 3 months. Overall, participants felt that the program was a good fit (Means: 3.69–4.62) and NRT was useful (Means: 4.38–4.46) on 5-point Likert scales. The community pharmacists reported that the QuitAid intervention was straightforward and well received by participants.

Conclusions:
A smoking cessation intervention that utilizes a standard documentation and billing platform could provide a highly disseminable avenue for pharmacist-delivered smoking cessation for hard-to-reach smokers. Because smoking cessation medications are primarily available through pharmacies, a unique opportunity exists for pharmacists to become the recognized community resource for providing smoking cessation medication support.

 
CITATIONS (1):
1.
Testing the feasibility of the QuitAid smoking cessation intervention in a randomized factorial design in an independent, rural community pharmacy
Melissa A. Little, Taylor Reid, Matthew Moncrief, Wendy Cohn, Kara P. Wiseman, Candace H. Wood, Wen You, Roger T. Anderson, Rebecca A. Krukowski
Pilot and Feasibility Studies
 
eISSN:2459-3087
Journals System - logo
Scroll to top